Lucid Diagnostics Inc.  ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. , announced that the American Foregut Society's (AFS) ...

The Temperature-Activated Generation of Signal (TAGS) technology was developed by Roche for its high-throughput PCR-based instruments.

In August 2024, elite runner David Roche shocked the ultra world and crossed the finish line first at the Leadville 100 race. He also shattered Matt Carpenter’s storied 2005 Leadville 100 course ...

Shares of Roche Holding AG fell after a poster highlighted side effects in an early-stage study of the Swiss pharmaceutical company’s experimental obesity medicine. The poster, released as part ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Roche Holding AG said it isn’t concerned about side effects in a small study of a weight-loss shot, after details about the trial sent shares tumbling on Monday. “We’re not alarmed at all ...

Shares of Roche (OTCQX:RHHBY) slid 5% Wednesday while shares of rivals Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) gained ground after Reuters reported that positive data released by Roche (OTCQX ...

When Roche's Genentech gained approval for Ocrevus in 2017, the first-in-class infused drug quickly became the best-selling treatment in a crowded multiple sclerosis (MS) market. Three years later ...

Roche is holding out hopes that its injectable obesity prospect could eventually demonstrate 25% weight loss in late-stage trials, the pharma’s head of metabolism R&D has told Fierce Biotech.

FRANKFURT, Sept 11 (Reuters) - Roche (ROG.S), opens new tab said on ... of CT-996 in studies of longer duration with larger sample sizes and slower titrations," the company said in a presentation ...

Sept 12 (Reuters) - Stories on Roche receiving FDA approval for an injectable version of its multiple sclerosis therapy are incorrect and are withdrawn. There will be no replacement story.